Accessibility Menu
Thermo Fisher Scientific logo

Thermo Fisher Scientific(NYSE) TMO

Current Price$561.49
Market Cap$212.69BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1980)+22,330%
5 Year+9%
1 Year+23%
1 Month+22%
Thermo Fisher Scientific last closing stock price
MetricPriceDate
Last closeUSD 572.322026-07-23
Thermo Fisher Scientific stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+5.36%USD 543.192026-07-16
1 month+21.94%USD 469.352026-06-23
3 month+21.97%USD 469.242026-04-24
Year to date-1.03%USD 578.302025-12-31
1 year+23.08%USD 465.012025-07-23
3 year+1.11%USD 566.062023-07-24
5 year+9.04%USD 524.872021-07-23
Since inception+22,330.19%USD 2.551980-08-27

Thermo Fisher Scientific Financials at a Glance

Market Cap

$212.69BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$46.34B

Net Income (TTM)

$6.98B

EPS (TTM)

$18.59

P/E Ratio

31.47

Dividend

$1.80

Beta (Volatility)

0.87 (Low)

Price

$561.49

Volume

36,217

Open

$570.00

Previous Close

$572.32

Daily Range

$560.23 - $570.59

52-Week Range

$435.27 - $643.99

Estimated Earnings Date

Oct 28, 2026

TMO: Motley Fool Moneyball Superscore

71

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is a prominent global leader in the science sector, providing a broad array of products and services that support scientific research and healthcare. With a diverse portfolio spanning life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products, the company plays a significant role in advancing scientific discovery and improving healthcare diagnostics.

Products and Services

Life Sciences Solutions: Products supporting biological research and biotech applications.

Analytical Instruments: Tools and technologies for chemical analysis and material science.

Specialty Diagnostics: Diagnostic test kits for various medical conditions.

Laboratory Products and Services: Comprehensive lab equipment and services for research support.

What Makes Thermo Fisher Scientific Inc. Special

Thermo Fisher distinguishes itself through its strong emphasis on innovation and consistent investment in research and development. This commitment enables it to create advanced technologies and solutions that meet evolving industry needs. Moreover, its strategic acquisitions expand its capabilities and market reach, strengthening its position as a key partner in science and healthcare industries.

Five Things You Need to Know

Thermo Fisher maintains a broad product portfolio that ensures stability across different market conditions.

Innovation is a core focus, with significant investment in R&D to drive technology advancements.

Strategic acquisitions enhance its capabilities and access to high-growth markets.

The company is guided by a leadership team dedicated to operational excellence and strategic growth.

Thermo Fisher's diversified offerings position it as a crucial partner in the scientific and healthcare sectors.

AI Generated • Apr 16, 2026

Industry

Life Sciences Tools and Services

Employees

125,000

CEO

Marc N. Casper, MBA

Headquarters

Waltham, MA 02451, US

TMO Financials

Key Financial Metrics (TTM)

Gross Margin

40.37%

Operating Margin

17.69%

Net Income Margin

15.06%

Return on Equity

13.35%

Return on Capital

8.60%

Return on Assets

6.17%

Earnings Yield

3.18%

Dividend Yield

0.31%

Payout Ratio

9.49%

Stock Overview

Market Cap

$212.69BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

371.62M

Volume

36.22K

Avg. Volume

2.36M

Financials (TTM)

Gross Profit

$18.71B

Operating Income

$8.20B

EBITDA

$10.94B

Operating Cash Flow

$9.01B

Capital Expenditure

-$1.70B

Free Cash Flow

$7.32B

Cash & ST Invst.

$4.06B

Total Debt

$42.55B

Thermo Fisher Scientific Performance Analysis

Thermo Fisher Scientific annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 44,915,000,00014.5%
20232023-12-31USD 42,857,000,000-4.6%
20242024-12-31USD 42,879,000,0000.1%
20252025-12-31USD 44,556,000,0003.9%
Thermo Fisher Scientific sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-272.5%
Q42025-12-319.8%
Q12026-03-28-9.9%
Q22026-06-279.0%
Thermo Fisher Scientific annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 17.64-9.3%
20232023-12-31USD 15.45-12.4%
20242024-12-31USD 16.547.1%
20252025-12-31USD 17.747.2%
Thermo Fisher Scientific sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-27-0.2%
Q42025-12-3122.0%
Q12026-03-28-15.0%
Q22026-06-275.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$11.99B

+10.5%

Gross Profit

$4.94B

+22.1%

Gross Margin

41.21%

N/A

Market Cap

$212.69BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.70M

N/A

Employees

125,000

N/A

Net Income

$1.74B

+7.4%

EBITDA

$2.57B

-8.1%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$4.06B

-36.4%

Total Debt

$42.55B

+20.8%

Accounts Receivable

$9.45B

-5.8%

Inventory

$5.63B

+1.2%

Long Term Debt

$39.18B

+18.7%

Short Term Debt

$3.37B

+52.1%

Return on Assets

6.17%

N/A

Return on Invested Capital

8.35%

N/A

Free Cash Flow

$1.68B

+51.6%

Operating Cash Flow

$2.13B

+51.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NVONovo Nordisk A/S
$49.22+2.16%
AMGNAmgen Inc.
$378.08+1.77%
ABTAbbott Laboratories
$103.18+2.41%
AZNAstraZeneca PLC
$169.51+0.74%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.54-0.03%
TQQQProShares Trust - ProShares UltraPro Qqq
$64.95-0.02%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$44.15+0.02%
CLFCleveland-Cliffs
$11.24+0.03%

Questions About TMO

What is the current price of Thermo Fisher Scientific?

Thermo Fisher Scientific is trading at $561.49 per share.

What is the 52-week range for Thermo Fisher Scientific?

Over the past 52 weeks, Thermo Fisher Scientific has traded between $435.27 and $643.99.

How much debt does Thermo Fisher Scientific have?

As of the most recent reporting period, Thermo Fisher Scientific reported total debt of $42.55B.

How much cash does Thermo Fisher Scientific have on hand?

Thermo Fisher Scientific reported $4.06B in cash and cash equivalents in its most recent financial results.

What is Thermo Fisher Scientific’s dividend yield?

Thermo Fisher Scientific currently has a dividend yield of 0.31%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.